Literature DB >> 30461691

Obstetric Care Consensus No. 7 Summary: Placenta Accreta Spectrum.

.   

Abstract

Placenta accreta spectrum, formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. The most favored hypothesis regarding the etiology of placenta accreta spectrum is that a defect of the endometrial-myometrial interface leads to a failure of normal decidualization in the area of a uterine scar, which allows abnormally deep placental anchoring villi and trophoblast infiltration. Maternal morbidity and mortality can occur because of severe and sometimes life-threatening hemorrhage, which often requires blood transfusion. Although ultrasound evaluation is important, the absence of ultrasound findings does not preclude a diagnosis of placenta accreta spectrum; thus, clinical risk factors remain equally important as predictors of placenta accreta spectrum by ultrasound findings. There are several risk factors for placenta accreta spectrum. The most common is a previous cesarean delivery, with the incidence of placenta accreta spectrum increasing with the number of prior cesarean deliveries. Antenatal diagnosis of placenta accreta spectrum is highly desirable because outcomes are optimized when delivery occurs at a level III or IV maternal care facility before the onset of labor or bleeding and with avoidance of placental disruption. The most generally accepted approach to placenta accreta spectrum is cesarean hysterectomy with the placenta left in situ after delivery of the fetus (attempts at placental removal are associated with significant risk of hemorrhage). Optimal management involves a standardized approach with a comprehensive multidisciplinary care team accustomed to management of placenta accreta spectrum. In addition, established infrastructure and strong nursing leadership accustomed to managing high-level postpartum hemorrhage should be in place, and access to a blood bank capable of employing massive transfusion protocols should help guide decisions about delivery location.(Table is included in full-text article.).

Entities:  

Mesh:

Year:  2018        PMID: 30461691     DOI: 10.1097/AOG.0000000000002984

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

Review 1.  Management of patients with suspected placenta accreta spectrum.

Authors:  S C Reale; M K Farber
Journal:  BJA Educ       Date:  2021-12-21

2.  Epidemiology of placenta previa accreta: a systematic review and meta-analysis.

Authors:  Eric Jauniaux; Lene Grønbeck; Catey Bunce; Jens Langhoff-Roos; Sally L Collins
Journal:  BMJ Open       Date:  2019-11-12       Impact factor: 2.692

3.  Uterine artery chemoembolization followed by hysteroscopic resection for management of retained placenta accreta with marked vascularity after evacuation of first-trimester miscarriage in angular pregnancy: A case report.

Authors:  Akihiro Takeda; Wataru Koike; Takaaki Katayama
Journal:  Case Rep Womens Health       Date:  2021-09-23

4.  Comparison of Magnetic Resonance Imaging of the Lower Uterine Segment in Pregnant Women with Central Placenta Previa with and without Placenta Accreta Spectrum from a Single Center.

Authors:  Shunyu Hou; Ye Song; Jiahui Wu; Liping Zhou; Suya Kang; Xi Chen; Lei Zhang; Yanli Lu; Yongfei Yue
Journal:  Med Sci Monit       Date:  2021-10-22

Review 5.  Pregnancy-Related Hysterectomy for Peripartum Hemorrhage: A Literature Narrative Review of the Diagnosis, Management, and Techniques.

Authors:  Dimitrios Tsolakidis; Dimitrios Zouzoulas; George Pados
Journal:  Biomed Res Int       Date:  2021-07-06       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.